BDBM292070 4-(2-{2,8-diazaspiro[4.5]decan-8-yl}-5-(1- methyl-1H-indazol-5-yl)-1,3-thiazol-4- yl)benzonitrile::US10100046, Example 5::US9902719, Example 5

SMILES Cn1ncc2cc(ccc12)-c1sc(nc1-c1ccc(cc1)C#N)N1CCC2(CCNC2)CC1

InChI Key InChIKey=YVYGHZOCUMQODE-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 292070   

TargetLysine-specific histone demethylase 1A(Human)
Celgene Quanticel Research

US Patent
LigandPNGBDBM292070(US10100046, Example 5 | 4-(2-{2,8-diazaspiro[4.5]d...)
Affinity DataIC50: 100nMAssay Description:The enzymatic assay of LSD1 activity is based on Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) detection. The inhibitory properties ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene Quanticel Research

US Patent
LigandPNGBDBM292070(US10100046, Example 5 | 4-(2-{2,8-diazaspiro[4.5]d...)
Affinity DataIC50: 100nMT: 2°CAssay Description:This assay determines the ability of a test compound to inhibit LSD1 demethylase activity. E. coli expressed full-length human LSD1 (Accession number...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent